Last reviewed · How we verify

NCT03325933

Resistance Training and Cardiometabolic Health

Terminated NA Last updated 19 April 2021
What this trial tests

NA trial testing High Load/Low Rep Resistance Training in Insulin Sensitivity in 62 participants. Terminated before completion.

Timeline
21 September 2017
Primary endpoint
31 August 2020
31 August 2020

Quick facts

Lead sponsorArizona State University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment62
Start date21 September 2017
Primary completion31 August 2020
Estimated completion31 August 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Arizona State University

Who can join

Adults 18 to 55, any sex, with Insulin Sensitivity or Endothelial Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate the relationship between resistance training load and repetitions on cardiometabolic outcomes. The primary objective of this clinical trial is to determine whether high load or low load resistance exercise training affects arterial stiffness in overweight or obese men and women. Our secondary objectives are to investigate the effects of high and low load RT on vascular function, cardiac structure, and markers of insulin sensitivity. Finally, we are going to preliminarily explore the effects of resistance training on intestinal bacteria.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Insulin Sensitivity

Currently open trials in the same condition.

Other Arizona State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03325933.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing